Physician profile
Daniel Masvidal
NPI 1760610752
$50,354.20
in general payments reported to CMS, 2019-2025
43 companies · $11K in 2025
The $11K reported for 2025 was more than what 82% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,458 · 2020: $3,750 · 2021: $12K · 2022: $8,462 · 2023: $4,937 · 2024: $5,690 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $6,538 · Consulting Fee: $2,300 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,599.83 |
| Travel and Lodging | $6,537.86 |
| Consulting Fee | $2,300.00 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18,429.18 | 2019-2025 | Aveir, Amplatzer Amulet, Perclose Prostyle |
| Biosense Webster, INC. | $8,084.48 | 2019-2025 | Carto 3, Nuvision Ice Catheter, Octaray Mapping Catheter |
| Boston Scientific Corporation | $7,110.11 | 2019-2025 | Farapulse, Watchman Access System, Rhythmia Mapping System |
| Biotronik INC. | $3,703.26 | 2019-2025 | Selectra, Amvia Edge, Solia |
| Medical Device Business Services, INC. | $3,000.00 | 2022 | |
| Medtronic, INC. | $2,874.79 | 2021-2025 | Affera Mapping System, Micra, Selectsecure |
| Acutus Medical, INC. | $2,220.54 | 2020-2023 | |
| Atricure, INC. | $908.31 | 2019-2024 | |
| Shockwave Medical, INC | $483.39 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Impulse Dynamics (USA) INC. | $348.78 | 2024 | Optimizer |
| Philips North America LLC | $337.86 | 2022-2023 | |
| Vektor Medical INC. | $327.85 | 2025 | Vmap |
| E.R. Squibb & Sons, L.L.C. | $287.58 | 2019-2023 | Camzyos |
| Janssen Pharmaceuticals, INC | $269.93 | 2019-2023 | Xarelto |
| Medtronic Vascular, INC. | $263.04 | 2019-2020 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $262.77 | 2024-2025 | Barostim Neo System |
| Inspire Medical Systems, INC. | $215.19 | 2021-2025 | Inspire |
| Cardiva Medical, INC. | $161.54 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Novartis Pharmaceuticals Corporation | $117.38 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $113.01 | 2019-2024 | Lifevest |
| Alnylam Pharmaceuticals INC. | $97.47 | 2019 | |
| Volta Medical INC | $92.75 | 2025 | Vx1 |
| Pfizer INC. | $88.37 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $63.89 | 2021-2023 | Verquvo |
| Sanofi-Aventis U.S. LLC | $52.05 | 2020-2023 | |
| Amgen INC. | $48.37 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $45.46 | 2020-2023 | Farxiga |
| Cardiovascular Systems INC. | $37.74 | 2022 | |
| Baxter Healthcare | $30.20 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Amarin Pharma, INC. | $30.08 | 2019-2020 | |
| Cleerly, INC. | $29.08 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.67 | 2019-2020 | |
| Abiomed | $25.40 | 2022 | |
| Acumed LLC | $24.67 | 2025 | Biobridge, Ribloc |
| Esperion Therapeutics, INC. | $21.82 | 2021 | |
| Cardiofocus, INC. | $21.29 | 2024 | Heartlight System |
| Convatec INC. | $17.67 | 2021 | |
| Portola Pharmaceuticals, LLC | $15.59 | 2019 | |
| Ge Healthcare | $15.02 | 2019 | |
| Preventice Services, LLC | $14.45 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $13.80 | 2023 | Uptravi, Opsumit |
| Elutia, INC. | $12.24 | 2022 | |
| Alexion Pharmaceuticals, INC. | $12.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Masvidal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.